Loading...
Loading...
SunTrust Robinson Humphrey initiated coverage on
Live Oak Bancshares Inc LOB with a Neutral rating. The target price for Live Oak Bancshares is set to $21. Live Oak Bancshares shares closed at $19.22 on Friday.
Analysts at JMP Securities initiated coverage on
Neos Therapeutics Inc NEOS with a Market Outperform rating. The target price for Neos Therapeutics is set to $32. Neos Therapeutics shares closed at $20.63 on Friday.
Analysts at Keefe Bruyette & Woods initiated coverage on
Live Oak Bancshares Inc LOB with a Outperform rating. The target price for Live Oak Bancshares is set to $24. Live Oak Bancshares shares closed at $19.22 on Friday.
JP Morgan initiated coverage on
Blue Buffalo Pet Products Inc BUFF with a Overweight rating. The target price for Blue Buffalo Pet Products is set to $32. Blue Buffalo Pet Products shares closed at $26.87 on Friday.
Analysts at Barclays initiated coverage on
Imprivata IncIMPR with a Overweight rating. The target price for Imprivata is set to $28. Imprivata shares closed at $18.72 on Friday.
Analysts at Wells Fargo initiated coverage on
MCBC Holdings IncMCFT with a Outperform rating. MCBC Holdings shares closed at $16.23 on Friday.
Analysts at B. Riley initiated coverage on
Loading...
Loading...
with a Buy rating. The target price for J C Penney is set to $12.50. J C Penney shares closed at $8.52 on Friday.
Analysts at Barclays initiated coverage on
Blue Buffalo Pet Products Inc BUFF with a Overweight rating. The target price for Blue Buffalo Pet Products is set to $34. Blue Buffalo Pet Products shares closed at $26.87 on Friday.
Analysts at Stifel Nicolaus initiated coverage on
Imprivata IncIMPR with a Buy rating. The target price for Imprivata is set to $24. Imprivata shares closed at $18.72 on Friday.
Analysts at Evercore ISI initiated coverage on
eBay IncEBAY with a Hold rating. The target price for eBay is set to $28. eBay shares closed at $28.26 on Friday.
Loading...
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in